207 related articles for article (PubMed ID: 25129200)
1. Longitudinal trajectories of aberrant behavior in fragile X syndrome.
Hustyi KM; Hall SS; Jo B; Lightbody AA; Reiss AL
Res Dev Disabil; 2014 Nov; 35(11):2691-701. PubMed ID: 25129200
[TBL] [Abstract][Full Text] [Related]
2. Factor Structure of the Aberrant Behavior Checklist in Individuals with Fragile X Syndrome: Clarifications and Future Guidance.
Aman MG; Norris M; Kaat AJ; Andrews H; Choo TH; Chen C; Wheeler A; Bann C; Erickson C
J Child Adolesc Psychopharmacol; 2020 Oct; 30(8):512-521. PubMed ID: 32746626
[No Abstract] [Full Text] [Related]
3. The aberrant behavior profile in Indonesian individuals with fragile X syndrome with limited genetic services.
Winarni TI; Sumekar TA; Sarjana W; Hardian H; Hagerman RJ; Faradz SM
Intractable Rare Dis Res; 2022 Nov; 11(4):215-218. PubMed ID: 36457587
[TBL] [Abstract][Full Text] [Related]
4. Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.
Wheeler A; Raspa M; Bann C; Bishop E; Hessl D; Sacco P; Bailey DB
Am J Med Genet A; 2014 Jan; 164A(1):141-55. PubMed ID: 24352914
[TBL] [Abstract][Full Text] [Related]
5. Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment.
Sansone SM; Widaman KF; Hall SS; Reiss AL; Lightbody A; Kaufmann WE; Berry-Kravis E; Lachiewicz A; Brown EC; Hessl D
J Autism Dev Disord; 2012 Jul; 42(7):1377-92. PubMed ID: 21972117
[TBL] [Abstract][Full Text] [Related]
6. Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome.
Del Hoyo Soriano L; Thurman AJ; Harvey DJ; Ted Brown W; Abbeduto L
J Neurodev Disord; 2018 Jun; 10(1):22. PubMed ID: 29925305
[TBL] [Abstract][Full Text] [Related]
7. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
Berry-Kravis E; Sumis A; Hervey C; Nelson M; Porges SW; Weng N; Weiler IJ; Greenough WT
J Dev Behav Pediatr; 2008 Aug; 29(4):293-302. PubMed ID: 18698192
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal profiles of adaptive behavior in fragile X syndrome.
Klaiman C; Quintin EM; Jo B; Lightbody AA; Hazlett HC; Piven J; Hall SS; Chromik LC; Reiss AL
Pediatrics; 2014 Aug; 134(2):315-24. PubMed ID: 25070318
[TBL] [Abstract][Full Text] [Related]
9. FMR1 mRNA from full mutation alleles is associated with ABC-C
Baker EK; Arpone M; Kraan C; Bui M; Rogers C; Field M; Bretherton L; Ling L; Ure A; Cohen J; Hunter MF; Santa María L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende A; Amor DJ; Godler DE
Sci Rep; 2020 Jul; 10(1):11701. PubMed ID: 32678152
[TBL] [Abstract][Full Text] [Related]
10. Specification of the neurobehavioral phenotype in males with fragile X syndrome.
Baumgardner TL; Reiss AL; Freund LS; Abrams MT
Pediatrics; 1995 May; 95(5):744-52. PubMed ID: 7724315
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of adaptive and maladaptive behaviors in fragile X males: growth, development, and profiles.
Fisch GS; Carpenter NJ; Holden JJ; Simensen R; Howard-Peebles PN; Maddalena A; Pandya A; Nance W
Am J Med Genet; 1999 Apr; 83(4):257-63. PubMed ID: 10208158
[TBL] [Abstract][Full Text] [Related]
12. Social Avoidance Emerges in Infancy and Persists into Adulthood in Fragile X Syndrome.
Roberts J; Crawford H; Hogan AL; Fairchild A; Tonnsen B; Brewe A; O'Connor S; Roberts DA; Abbeduto L
J Autism Dev Disord; 2019 Sep; 49(9):3753-3766. PubMed ID: 31165359
[TBL] [Abstract][Full Text] [Related]
13. Do Children With Fragile X Syndrome Show Declines or Plateaus in Adaptive Behavior?
Hahn LJ; Brady NC; Warren SF; Fleming KK
Am J Intellect Dev Disabil; 2015 Sep; 120(5):412-32. PubMed ID: 26322389
[TBL] [Abstract][Full Text] [Related]
14. Developmental divergence: motor trajectories in children with fragile X syndrome with and without co-occurring autism.
Will EA; Bishop SL; Roberts JE
J Neurodev Disord; 2019 Oct; 11(1):23. PubMed ID: 31586494
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Hyperactivity, Impulsivity, and Attention Problems on Social Functioning in Adolescents and Young Adults With Fragile X Syndrome.
Chromik LC; Quintin EM; Lepage JF; Hustyi KM; Lightbody AA; Reiss AL
J Atten Disord; 2019 Jan; 23(2):181-188. PubMed ID: 25731183
[TBL] [Abstract][Full Text] [Related]
16. A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
Heussler H; Cohen J; Silove N; Tich N; Bonn-Miller MO; Du W; O'Neill C; Sebree T
J Neurodev Disord; 2019 Aug; 11(1):16. PubMed ID: 31370779
[TBL] [Abstract][Full Text] [Related]
17. Arbaclofen in fragile X syndrome: results of phase 3 trials.
Berry-Kravis E; Hagerman R; Visootsak J; Budimirovic D; Kaufmann WE; Cherubini M; Zarevics P; Walton-Bowen K; Wang P; Bear MF; Carpenter RL
J Neurodev Disord; 2017; 9():3. PubMed ID: 28616094
[TBL] [Abstract][Full Text] [Related]
18. Lifespan trajectory of affect in Cornelia de Lange syndrome: towards a neurobiological hypothesis.
Groves L; Moss J; Crawford H; Nelson L; Stinton C; Singla G; Oliver C
J Neurodev Disord; 2019 Jun; 11(1):6. PubMed ID: 31174462
[TBL] [Abstract][Full Text] [Related]
19. Articulation rate and vowel space characteristics of young males with fragile X syndrome: preliminary acoustic findings.
Zajac DJ; Roberts JE; Hennon EA; Harris AA; Barnes EF; Misenheimer J
J Speech Lang Hear Res; 2006 Oct; 49(5):1147-55. PubMed ID: 17077221
[TBL] [Abstract][Full Text] [Related]
20. Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study.
Haessler F; Gaese F; Huss M; Kretschmar C; Brinkman M; Peters H; Elstner S; Colla M; Pittrow D
BMC Psychiatry; 2016 Sep; 16(1):318. PubMed ID: 27612457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
